Concepedia

Author

Ravi Vij

Washington University in St. LouisORCID

Also Known As

Carolyn M. Hutter, Gentile, Teresa, Hsu, Jack W., Hwang, A.E., Keith Stockerl-Goldstein, Kharfan-Dabaja, Mohamed, Kharfan-Dabaja, Mohamed A., Ku, Grace H., Lekakis, Lazaros, R Vij

959

Publications

27.7K

Citations

73

H-Index

155

Concepts

All Affiliations

Washington University in St. LouisEmory UniversityHackensack University Medical CenterDana-Farber Cancer InstituteMayo Clinic in Arizona
RV

About

Ravi Vij is an author at Washington University in St. Louis specializing in medicine, oncology, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

41

103

7.6K

2

Health Sciences

20

43

1.9K

3

Engineering

3

3

676

4

Natural Sciences

1

1

151

5

Nursing

1

1

10

Ravi Vij

×

299

Publications

24.8K

Citations

72

H-Index

YearCitations

Initial genome sequencing and analysis of multiple myeloma

Michael A. Chapman, Michael S. Lawrence, Jonathan J. Keats,

Nature

2011

1.4K

Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma

Philip L. McCarthy, Kouros Owzar, Craig C. Hofmeister,

New England Journal of Medicine

2012

1.1K

Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted Therapy

Jens G. Lohr, Petar Stojanov, Scott L. Carter,

Cancer Cell

2014

988

<i>TP53</i> and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes

John S. Welch, Allegra A. Petti, Christopher A. Miller,

New England Journal of Medicine

2016

774

Oral Selinexor–Dexamethasone for Triple-Class Refractory Multiple Myeloma

Ajai Chari, Dan T. Vogl, Maria Gavriatopoulou,

New England Journal of Medicine

2019

655

A phase 2 study of single-agent carfilzomib (PX-171-003-A1) in patients with relapsed and refractory multiple myeloma

David S. Siegel, Thomas G. Martin, Michael Wang,

Blood

2012

654

Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia

Stefan O. Ciurea, Mei-Jie Zhang, Andrea A. Bacigalupo,

Blood

2015

645

Ide-cel or Standard Regimens in Relapsed and Refractory Multiple Myeloma

Paula Rodríguez‐Otero, Sikander Ailawadhi, Bertrand Arnulf,

New England Journal of Medicine

2023

627

Outcomes of patients with multiple myeloma refractory to CD38-targeted monoclonal antibody therapy

Ujjawal H. Gandhi, Robert F. Cornell, Arjun Lakshman,

Leukemia

2019

597

Efficacy of venetoclax as targeted therapy for relapsed/refractory t(11;14) multiple myeloma

Shaji Kumar, Jonathan L. Kaufman, Cristina Gasparetto,

Blood

2017

517

Page 1